Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure (RENEU-HF)

NCT06369298 is registered in ClinicalTrials.gov with Salubris Biotherapeutics Inc as lead sponsor.

NCT NCT06369298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure (RENEU-HF)
Lead sponsor
Salubris Biotherapeutics Inc
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 28, 2024
Completion date
October 31, 2026
Enrollment
282 (estimated)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, heart failure with reduced ejection fraction